Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ASND
CRL
Add up to 3 more stocks
ASND
Ascendis Pharma A/S
+0.07%
$228.03+0.16Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.16B
52W Range
$186.05 - $282.15
CRL
Charles River Laboratories International, Inc.
+7.09%
$310.77+20.58Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$14.97B
52W Range
$146.20 - $312.05
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.33 | N/A |
| Forward P/E | N/A | 27.39 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 8.64 | 5.27 |
| P/S Ratio | 11.59 | 3.74 |
| P/FCF Ratio | 36.61 | 40.39 |
| EV/EBITDA | 93.79 | 22.49 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 90.2% | 32.2% |
| Operating Margin | -18.9% | 12.3% |
| Net Margin | 71.1% | -6.0% |
| ROE | 53.0% | -8.4% |
| ROA | 33.3% | -3.2% |
| ROIC | 5.8% | 7.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.99 | 1.35 |
| Quick Ratio | 2.32 | 1.04 |
| Debt/Equity | 0.31 | 1.07 |
| Interest Coverage | -1.69 | 4.74 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.